Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study.
about
Comprehensive immunophenotyping of cerebrospinal fluid cells in patients with neuroimmunological diseasesClinical correlates of grey matter pathology in multiple sclerosisBrain viscoelasticity alteration in chronic-progressive multiple sclerosisMRI evaluation of grey matter atrophy and disease course in multiple sclerosis: an overview of current knowledge.Therapeutic strategies for relapsing-remitting multiple sclerosis: a special focus on reduction of grey matter damage as measured by brain atrophy.Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.Clinical-magnetic resonance imaging correlations in multiple sclerosis.The Effects of Meditation on Grey Matter Atrophy and Neurodegeneration: A Systematic Review.Longitudinal imaging in dementia.MR imaging of gray matter involvement in multiple sclerosis: implications for understanding disease pathophysiology and monitoring treatment efficacy.Progressive multiple sclerosis and gray matter pathology: an MRI perspective.Focal and diffuse cortical degenerative changes in a marmoset model of multiple sclerosisThe role of advanced magnetic resonance imaging techniques in primary progressive MS.Gray matter imaging in multiple sclerosis: what have we learned?Myelin water imaging reflects clinical variability in multiple sclerosisPrimary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?Gray matter atrophy in multiple sclerosis: a longitudinal study.Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine.Cord atrophy separates early primary progressive and relapsing remitting multiple sclerosisMagnetisation transfer ratio in the normal appearing white matter predicts progression of disability over 1 year in early primary progressive multiple sclerosis.Quantitative MRI demonstrates abnormality of the fornix and cingulum in multiple sclerosisNeuroradiological evaluation of demyelinating diseaseImpaired small-world efficiency in structural cortical networks in multiple sclerosis associated with white matter lesion load.Temporal and spatial evolution of grey matter atrophy in primary progressive multiple sclerosis.Relationship between brain volume loss and cognitive outcomes among patients with multiple sclerosis: a systematic literature review.Volumetric Analysis from a Harmonized Multisite Brain MRI Study of a Single Subject with Multiple Sclerosis.Secondary Progressive Multiple Sclerosis: Definition and Measurement.The clinical perspective: How to personalise treatment in MS and how may biomarkers including imaging contribute to this?Lesion Expansion in Experimental Demyelination Animal Models and Multiple Sclerosis Lesions.Regional gray matter atrophy and neuropsychologcal problems in relapsing-remitting multiple sclerosis.Hippocampal atrophy in relapsing-remitting and primary progressive MS: a comparative study.Putaminal alteration in multiple sclerosis patients with spinal cord lesions.Interferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy.Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes.MRI measures show significant cerebellar gray matter volume loss in multiple sclerosis and are associated with cerebellar dysfunction.Grey matter atrophy is associated with disability increase in natalizumab-treated patients.Brain Volume Loss During the First Year of Interferon-Beta Treatment in Multiple Sclerosis: Baseline Inflammation and Regional Brain Volume Dynamics.Brain atrophy 15 years after CIS: Baseline and follow-up clinico-radiological correlations.Brain atrophy and disability worsening in primary progressive multiple sclerosis: insights from the INFORMS study.Clinical impact of early brain atrophy in clinically isolated syndromes
P2860
Q24273331-932D0EA4-8C10-4801-83DF-8C1E653D971CQ26999302-D21BAE48-A302-4B6A-BEA2-2B8E86DCEEFAQ30471299-266CFE06-6E12-402E-B5F0-DDE23D2A2D65Q30769070-BD675044-D7D2-48AB-B302-5BE6E05540E1Q30869048-113B9D3D-F719-4D8F-9903-59D54A626D6BQ31027249-583844A9-C5A1-4D13-9833-8EF826C8B637Q31027945-1BD72DB9-C04E-4CA8-8DAF-CF688A1F5D55Q31149482-6CA8A737-7536-4ED0-B9CA-7BCCDA34BBB8Q31153983-1DADFF45-5C19-4EF0-BE6C-7A76B839D2E4Q33521563-B3A1A287-F8FA-4A5A-9141-E42C9EE64408Q33852170-807F0BE7-FE06-4504-B9AE-FDB0BBBC7AF1Q33869433-28263E77-573F-4CA7-9E2F-37AE24F98C1FQ33981654-6CA865EA-298A-4846-9C68-01C9196EF89CQ34094761-1FACFC9B-F008-487E-A1C0-6030B1C5A709Q34095719-740A6D17-A0F4-4A95-9739-D755A493D05CQ34156824-9CE54B63-8B3F-4BCB-9BD6-52EB6659B033Q34801849-C5CC9929-7E1E-4CB6-9126-FB7A3302DE08Q35997017-700DC656-A694-47B7-A27C-873C864CE920Q36143116-FB0D4B9A-5B38-41A2-91C6-4BF1B6FB1608Q36226746-C748020C-D4D7-4EE3-BFF6-1C9DD4E96EDCQ36651323-D2A2CC15-6823-47AD-9950-2D045D5B805EQ36999734-25B5BBEA-7285-4BA4-81D4-643CF9363537Q37472310-7CC8D9E1-CAE0-4EBA-BBDE-DB346755C495Q37504560-AD738835-D621-4898-A9F1-EF2BFF20F04FQ38625426-D1A259C0-2C48-433B-9864-A4E3EC9CC228Q38713119-1FF72825-88EC-4B55-B838-4A984F123D61Q38831720-B4A20DF1-72AA-4CD5-A6F7-9A412DD36203Q38910574-3216C608-4D92-44D6-9EE4-4B6E10D7B942Q38964699-6A9FBABD-D2B9-44E7-B858-974DB6909FDEQ41780757-B9B52078-4316-492F-8390-C8832A31498DQ48128098-0894A79A-6498-4688-89A9-B2AA630659E0Q48179442-3F226455-45BE-4753-8360-679CA9313003Q48186695-690C554B-C7F9-4D5F-90A2-7C7780900B9CQ48210503-48F6102E-18F3-498A-87B9-C1E7F64CD7B8Q48601876-163D0210-4511-4DF0-85A6-0559627431B9Q48651177-2784FBDC-7A48-437A-8708-BB230676B0C9Q48865505-565C9BB0-9E9C-42B0-8699-03D50976BB80Q52097333-0F2DC5F6-7194-471E-B5E2-041B6075C05EQ52645792-83FDE86F-6338-4DD2-89BF-6FF8990A6FBBQ57601852-81F04901-02B4-43CF-B6F5-494327265097
P2860
Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Grey and white matter volume c ...... lerosis: a longitudinal study.
@en
Grey and white matter volume c ...... lerosis: a longitudinal study.
@nl
type
label
Grey and white matter volume c ...... lerosis: a longitudinal study.
@en
Grey and white matter volume c ...... lerosis: a longitudinal study.
@nl
prefLabel
Grey and white matter volume c ...... lerosis: a longitudinal study.
@en
Grey and white matter volume c ...... lerosis: a longitudinal study.
@nl
P2093
P356
P1433
P1476
Grey and white matter volume c ...... lerosis: a longitudinal study.
@en
P2093
David H Miller
Gordon T Ingle
Jaume Sastre-Garriga
Lluís Ramió-Torrentà
Mara Cercignani
P304
P356
10.1093/BRAIN/AWH498
P407
P577
2005-04-07T00:00:00Z